Productive and non-productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain

Journal of Neuroscience Research

Volumn 44, Issue 3, 1996, Pages 263-271

  Daniels Holgate, P U ^a   Dolly, J O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

autoradiography; biotinylated or iodinated botulinum neurotoxin A; dystonias; neuromuscular junction; spasticities

Indexed keywords

BOTULINUM TOXIN A;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BOTULISM; CHOLINERGIC NERVE; CONTROLLED STUDY; DYSTONIA; MOUSE; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SPASTICITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BIOTIN; BOTULINUM TOXINS; IODINE RADIOISOTOPES; MICE; MOTOR ENDPLATE; MOTOR NEURONS; NEUROMUSCULAR JUNCTION; PARALYSIS;

EID: 0029863395     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960501)44:3<263::AID-JNR7>3.0.CO;2-E     Document Type: Article

References (26)

1. Arribas M, Blasi J, Egea G, Farinas I, Solsona C, Marsal J (1993): High resolution labeling of cholinergic nerve terminals using a specific fully active biotinylated botulinum neurotoxin type A. J Neurosci Res 36:635-645.
2. Bandyopadhyay S, Clark AW, DasGupta BR, Sathyamoorthy V (1987): Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis. J Biol Chem 262:2660-2663.
3. 125I-labeled botulinum neurotoxins with nerve terminals. I Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol 103:521-534.
4. 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evi-dence for its uptake into motor nerves via acceptor-mediated endocytosis. J Cell Biol 103:535-544.
5. Black JD, Dolly JO (1987): Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems. Neuroscience 23:767-779.
6. Blasi J, Egea G, Castiella MJ, Arribas M, Solsona C, Richardson PJ, Marsal J (1992): Binding of botulinum neurotoxin to pure cholinergic nerve terminals isolated from the electric organ of Torpedo. J Neural Transm 90:87-102.
7. Brin MF (1990): Assessment: The clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 40:1332-1336.
8. de Paiva A, Dolly JO (1990): Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes. FEBS Lett 277:171-174.
9. de Paiva A, Poulain B, Lawrence GW, Shone CC, Tauc L, Dolly JO (1993): A role for the interchain disulphide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly. J Biol Chem 268:20838-20844.
10. Dolly JO (1992): Peptide toxins that alter neurotransmitter release. In Herken H, Hucho F (eds): "Handbook of Experimental Pharmacology: Selective Neurotoxicity." Vol 102. Berlin: Springer-Verlag, pp 681-717.
11. + channels probed with botulinum neurotoxins and dendrotoxin. In Dolly JO (ed): "Neurotoxins in Neurochemistry." Chichester: Ellis Horwood Limited, pp 79-99.
12. Dolly JO, de Paiva A, Foran P, Lawrence G, Daniels-Holgate P, Ashton A (1994): Probing the process of transmitter release with botulinum and tetanus neurotoxins. Semin Neurosci 6:149-158.
13. Hayashi T, McMahon H, Yamasaki S, Binz T, Hata Y, Südhof TC, Niemann H (1994): Synaptic vesicle membrane fusion complex: Action of clostridial neurotoxins on assembly. EMBO J 13:5051-5061.
14. Hesse S, Jahnke MT, Luecke D, Mauritz KH (1995): Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 201:1-4.
15. Karnovsky MJ, Roots L (1964): A "direct-colouring" thiocholine method for cholinesterases. J Histochem Cytochem 212:219-223.
16. Maisey EA, Wadsworth DF, Poulain B, Shone CC, Melling J, Gibbs P, Tauc L, Dolly JO (1988): Involvement of constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release. Eur J Biochem 177:683-691.
17. Montecucco C, Schiavo G (1994): Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13:1-8.
18. Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M, Kozaki S (1994): Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269:10498-10503.
19. Parton RG, Ockleford CD, Critchley DR (1988): Tetanus toxin binding to mouse spinal cord cells: An evaluation of the role of gangliosides in toxin internalization. Brain Res 475:118-127.
20. Pierce EJ, Davidson MD, Parton RG, Habig WH, Critchley DR (1986): Characterisation of tetanus toxin binding to rat brain membranes. Evidence for a high-affinity proteinase-sensitive receptor. Biochem J 236:845-852.
21. Simpson LL (1980): Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 212:16-21.
22. Simpson LL (1981): The origin, structure and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155-188.
23. Simpson LL (1989): "Botulinum Neurotoxin and Tetanus Toxin." New York: Academic Press.
24. Slatin SL, Xiao-Qing Q, Jakes KS, Finkelstein A (1994): Identification of a translocated protein segment in a voltage-dependent channel. Nature 371:158-161.
25. Williams RS, Tse C-K, Dolly JO, Hambleton P, Melling J (1983): Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem 131:437-445.
26. Zhou L, de Paiva A, Liu D, Aoki R, Dolly JO (1995): Expression and purification of the light chain of botulinum neurotoxin A: A single mutation abolishes its cleavage of SNAP-25 and neurotoxicity after reconstitution with heavy chain. Biochemistry 34:15175-15181.